Stem Cell Therapy against Ischemic Heart Disease.

Area of Science:

• Cardiology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Ischemic heart disease (IHD) is a major global health burden, leading to myocardial infarction and heart failure.
• Cardiomyocytes have limited regenerative capacity, contributing to disease progression despite medical advancements.
• Ischemia-reperfusion injury and oxidative stress further impair cardiac function post-myocardial infarction.

Purpose of the Study:

• To review the therapeutic applications of stem cells in various forms of ischemic heart disease.
• To summarize experimental and clinical findings on stem cell-based therapies for IHD.
• To explore the proposed mechanisms of action for stem cells and exosomes in cardiac repair.

Main Methods:

• Review of experimental and clinical studies on stem cell therapy for ischemic heart disease.
• Analysis of data concerning different stem cell types (mesenchymal stem cells, progenitor cells, iPSCs) and exosomes.
• Examination of proposed therapeutic mechanisms, including paracrine effects.

Main Results:

• Various stem cell types demonstrate therapeutic potential in preclinical and clinical studies of IHD.
• Stem cell-derived exosomes are emerging as a significant therapeutic avenue.
• Paracrine signaling plays a crucial role in the observed benefits of stem cell therapies.

Conclusions:

• Stem cell therapy, including the use of exosomes, offers a promising strategy for treating ischemic heart disease.
• Further research is needed to validate findings and address potential issues like data integrity.
• Understanding stem cell mechanisms is key to optimizing regenerative therapies for cardiac repair.